CVS Ousts Karen Lynch as C.E.O. and Shares Fall
Published On Oct 18, 2024, 10:05 AM
CVS Health has ousted its CEO, Karen Lynch, due to sluggish growth and disappointing financial performance. Following her removal, the company's shares fell sharply as they scrapped previous earnings forecasts amid rising medical costs, particularly from Aetna, CVS's insurance division. The board has appointed David Joyner, currently the head of CVS Caremark, as the new CEO, citing his knowledge of the business as key to navigating its current struggles. The company is also planning to lay off approximately 3,000 employees and has seen a significant drop in its stock value this year.